Skip to main content
. 2019 Feb 25;8(2):275. doi: 10.3390/jcm8020275

Table 2.

Genome-wide associations of 29 SNPs with intracranial aneurysm.

Gene Chr. SNP Class M/m a MAF b OR c L95 c U95 c P c Power d
PRDM2 1p36.21 rs61775135 intron C/A 0.16/0.41 0.32 0.23 0.43 3.6E-13 0.42
GBA 1q22 rs75822236 R535H C/T 0.33/0.01 161.40 53.86 483.60 1.1E-19 1.00
FMO4 1q24.3 rs3737926 F281F C/T 0.16/0.37 0.36 0.27 0.50 1.8E-10 0.32
RNF144A 2p25.1 rs6741819 intron C/T 0.13/0.37 0.25 0.18 0.36 4.0E-14 0.72
FLJ45964 2q37.3 rs59626274 stop-gained C/T 0.13/0.36 0.26 0.18 0.37 5.8E-14 0.71
LINC01237 2q37.3 rs78458145 intron G/A 0.17/0.4 0.24 0.17 0.35 3.1E-15 0.68
SPCS3 4q34.2 rs17688188 intergenic G/A 0.11/0.33 0.27 0.19 0.38 6.0E-13 0.73
TCF24 8q13.1 rs112859779 G141S C/T 0.1/0.33 0.19 0.12 0.28 3.3E-16 0.94
C9orf92 9p22.3 rs12350582 intergenic A/G 0.33/0.18 2.43 1.79 3.31 1.5E-08 0.20
LINGO2 9p21.1 rs56942085 intron G/A 0.1/0.03 6.11 3.20 11.64 3.9E-08 0.78
TMOD1 9q22.33 rs1052270 intron C/T 0.27/0.42 0.41 0.30 0.56 2.7E-08 0.15
SUSD1 9q31.3 rs79461840 intron T/C 0.13/0.02 6.92 3.55 13.49 1.4E-08 0.65
LINC00474 9q33.1 rs4979583 intergenic C/T 0.41/0.24 2.45 1.82 3.31 4.6E-09 0.24
OLFML2A 9q33.3 rs79134766 A208T G/A 0.07/0.37 0.14 0.09 0.21 1.7E-19 0.96
MYEOV 11q13.3 rs76855873 intron C/T 0.16/0.37 0.33 0.24 0.46 1.2E-11 0.43
ARHGAP32 11q24.3 rs371331393 stop-gained G/A 0.32/0.02 43.57 21.84 86.95 9.3E-27 1.00
CD163L1 12p13.31 rs138525217 splice-site C/T 0.31/0.01 75.98 32.13 179.70 6.2E-23 1.00
SLC2A14 12p13.31 rs118107419 intron C/A 0.14/0.39 0.25 0.17 0.35 1.4E-14 0.67
DRAM1 12q23.2 rs7964241 e intergenic A/G 0.35/0.21 2.49 1.81 3.42 2.0E-08 0.25
CUL4A 13q34 rs74115822 intergenic G/A 0.19/0.03 6.25 3.58 10.90 1.1E-10 0.80
LINC02130 16p13.12 rs11646803 intron C/T 0.28/0.48 0.45 0.35 0.58 4.8E-10 0.06
LOC102724084 16q23.2 rs75861150 intron T/C 0.02/0.16 0.14 0.07 0.28 1.3E-08 1.00
SCARF1 17p13.3 rs3744644 E639D G/C 0.18/0.35 0.39 0.28 0.54 6.0E-09 0.26
MINK1 17p13.2 rs72835045 intron G/A 0.11/0.33 0.25 0.17 0.37 1.7E-12 0.79
SLC47A1 17p11.2 rs2440154 e intron G/A 0.28/0.13 2.67 1.90 3.75 1.4E-08 0.26
NAPA-AS1 19q13.32 rs55800589 intron G/C 0.32/0.4 0.38 0.29 0.49 3.4E-13 0.23
DSCAM 21q22.2 rs727333 intron C/A 0.14/0.38 0.26 0.18 0.36 3.7E-14 0.69
LRRC3 21q22.3 rs116969723 P63P G/A 0.11/0.35 0.24 0.16 0.34 3.8E-15 0.81
SLC5A4-AS1 22q12.3 rs117398778 intron T/C 0.21/0.07 3.74 2.43 5.75 2.0E-09 0.56

Chr. chromosome; L95, lower 95% confidence interval; OR, odds ratio; U95, upper 95% confidence interval. a M/m, major/minor allele type; b MAF, minor allele frequency in case (left) and control (right); c OR, 95% confidence interval, and p-value were estimated in the multivariate logistic regression model after adjustment for age, sex, hypertension, diabetes, hyperlipidemia, cigarette smoking, and four principal components; d The statistical power for each SNP was estimated by performing the web-based Genetic Power Calculator (http://zzz.bwh.harvard.edu/gpc/cc2.html) using parameters, such as 5% prevalence of intracranial aneurysm, MAF in control, OR under an additive model, D-prime 0.8, 1:1.18 case-control ratio (296 controls/250 cases = 1.18), and type 1 error rate of 5e-8 (genome-wide significance threshold); e One SNP shown in a pairwise linkage disequilibrium (LD, r2 < 0.8): rs7964241 and rs56168082 (r2 = 0.81); rs2440154 and rs2289668 (r2 = 1.0).